Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Clinical trial NCT03451045 · COMPLETED
Trial details
- NCT number
- NCT03451045
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-22
- Primary completion
- 2020-06-17
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.